Capecitabine Market – Industry Analysis and Forecast 2024-2030
Capecitabine Market is anticipated to reach USD 0.98 Bn by 2030 from USD 0.64 Bn in 2023 at a CAGR of 6.2 % during a forecast period.
Capecitabine is a prodrug that operates as a nucleoside metabolic inhibitor. The chemical is transformed into fluorouracil, which inhibits DNA synthesis and slows cancer cell development. It's taken orally and is authorized to treat a variety of tumors, including metastatic colorectal cancer, breast cancer, and others.